Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982789priorityCriticalpatent/ECSP982789A/en
Publication of ECSP982789ApublicationCriticalpatent/ECSP982789A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invención se refiere al tratamiento de la disfunción eréctil con una combinación de (1) un compuesto seleccionado entre antagonistas de los receptores alfa adrenérgicos y (2) un compuesto seleccionado entre los agentes que elevan los niveles de cGMP. Se prefiere como elevador de cGMP PDE al sildenafilo o una sal farmacéuticamente aceptable del mismo. También se incluyen composiciones y estuches que comprenden tales compuestos para el tratamiento de la impotencia.This invention relates to the treatment of erectile dysfunction with a combination of (1) a compound selected from among alpha adrenergic receptor antagonists and (2) a compound selected from among agents that raise cGMP levels. Sildenafil or a pharmaceutically acceptable salt thereof is preferred as a cGMP PDE enhancer. Also included are compositions and kits comprising such compounds for the treatment of impotence.
ECSP9827891998-12-161998-12-16
EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE
ECSP982789A
(en)
BETA- AMINO TETRAHYDROIMIDAZOL (1,2-A) PIRAZIN AND TETRAHYDROTRIOAZOLO INHIBITORS (4,3-A) PIRAZINAS AS DEPETIDIL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES
PHARMACEUTICAL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS FOR USE WITH A SECOND COMPOSITION TO OBTAIN AN IMPROVEMENT IN THE THERAPEUTIC EFFECT, A KIT WHICH CONTAINS AND USE OF A COMPOUND TO PREPARE THE COMPOSITION